SLU-PP-915 60x 5mg Capsules

Overview: SLU-PP-915 is a synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ and ERRγ), developed at Saint Louis University as a successor compound of the SLU-PP series (Hampton et al., Eur J Med Chem 2023). It is a small molecule carrying a boronic acid group (C₁₇H₁₃BFNO₃S, 341.16 g/mol), not a peptide. This format supplies the compound in 60 capsules with 5 mg declared content each – intended for workflows where weighing out per assay is not required.

Research Purpose: Investigation of the ERR receptor family in preclinical in vitro models – receptor affinity and selectivity profile compared with SLU-PP-332, the PGC-1α pathway, mitochondrial biogenesis and expression of oxidative-metabolism genes (e.g. PDK4, PGC-1α) in cell models. The content figure per unit supports assay planning in the laboratory.

Specifications: ≥99% purity (HPLC + LC-MS), CAS 2285432-92-8, lot tracking, 60 units per container. Certificate of Analysis per batch available on request. Research Use Only – not intended for use in humans, not for therapeutic purposes.

Availability: in stock at our EU warehouse. If payment arrives Mon–Sat by 2 pm CET, you receive tracking the same day; delivery within the EU takes 2–6 business days.